Status:

COMPLETED

Cost and Cost-effectiveness of PTB+ Treatment in Southern Ethiopia

Lead Sponsor:

University of Bergen

Conditions:

Smear-positive TB Cases

Eligibility:

All Genders

Brief Summary

Evidences for policy making and decision related to the cost of delivering tuberculosis (TB) control is lacking in Ethiopia. The investigators aimed to determine the cost and cost-effectiveness of inv...

Detailed Description

Two treatment options were compared - health facility and community DOT. In 1995, Ethiopia adopted World Health Organization (WHO) recommended DOTS strategy for TB control. The treatment regimen for n...

Eligibility Criteria

Inclusion

  • Pulmonary tuberculosis suspects of any age and sex

Exclusion

  • Healthy individuals or non tuberculosis patients

Key Trial Info

Start Date :

September 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2008

Estimated Enrollment :

229 Patients enrolled

Trial Details

Trial ID

NCT00913172

Start Date

September 1 2006

End Date

April 1 2008

Last Update

May 17 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

YAHC

Irgalem, Snnpr, Ethiopia, 72

Cost and Cost-effectiveness of PTB+ Treatment in Southern Ethiopia | DecenTrialz